trending Market Intelligence /marketintelligence/en/news-insights/trending/rwjpjdablvpgd_6p6x75mq2 content esgSubNav
In This List

Anteo Diagnostics extends interim CEO's appointment

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Anteo Diagnostics extends interim CEO's appointment

Anteo Diagnostics Ltd. said Christopher Parker will remain as the company's interim CEO until June 30, 2019.

In April, Parker was appointed to the interim CEO post for an initial three-month period.

The contract extension will provide business continuity as the company executes its development strategy in the battery and diagnostic markets.

Australia-based Anteo Diagnostics is engaged in the development and commercialization of products for the life sciences, clinical diagnostics and bioseparations sectors.